Chugai Pharmabody Research Pte. Ltd. (CPR) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Biopolis in Singapore , it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering technologies, such as recycling antibody®, sweeping antibody®, bispecific antibody, various Fc engineered antibodies, and other new antibody engineering technologies that are under development.

• Provide full spectrum of secretarial support to CEO and Administration Head including but not limited to calendar management, coordination of meetings, travel arrangements, preparation of presentation materials and expense claims.
• Coordinate and liaise with internal and external parties for al...